{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:17:46Z","timestamp":1777576666950,"version":"3.51.4"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"16","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-75-10030"],"award-info":[{"award-number":["22-75-10030"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG071310"],"award-info":[{"award-number":["R01AG071310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000935","name":"RSF","doi-asserted-by":"publisher","award":["22-75-10030"],"award-info":[{"award-number":["22-75-10030"]}],"id":[{"id":"10.13039\/100000935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is reported to be the most common type of autosomal dominant cerebellar ataxia (ADCA). SCA3 patients suffer from a progressive decline in motor coordination and other disease-associated symptoms. Moreover, recent studies have reported that SCA3 patients also exhibit symptoms of cerebellar cognitive affective syndrome (CCAS). We previously observed signs of CCAS in mouse model of SCA3. Particularly, SCA3-84Q mice suffer from anxiety, recognition memory decline, and also exhibit signs of low mood and aversion to activity. Here we studied the effect of long-term injections of SK channels activator chlorzoxazone (CHZ) together and separately with the folic acid (FA) on the cerebellar Purkinje cell (PC) firing and histology, and also on the motor and cognitive functions as well as mood alterations in SCA3-84Q hemizygous transgenic mice. We realized that both CHZ and CHZ-FA combination had similar positive effect on pure cerebellum impairments including PC firing precision, PC histology, and motor performance in SCA3-84Q mice. However, only the CHZ-FA combination, but not CHZ, had significantly ameliorated the signs of anxiety and depression, and also noticeably improved recognition memory in SCA3-84Q mice. Our results suggest that the combination therapy for both ataxia and non-motor symptoms is required for the complex treatment of ADCA.<\/jats:p>","DOI":"10.1093\/hmg\/ddae079","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T13:45:53Z","timestamp":1715348753000},"page":"1406-1419","source":"Crossref","is-referenced-by-count":6,"title":["A combination of chlorzoxazone and folic acid improves recognition memory, anxiety and depression in SCA3-84Q mice"],"prefix":"10.1093","volume":"33","author":[{"given":"Ksenia S","family":"Marinina","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Neurodegeneration, Peter the Great St. Petersburg Polytechnic University , 29 Polytechnicheskaya str., St. Petersburg 195251 , Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya B","family":"Bezprozvanny","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Texas Southwestern Medical Center , 5323 Harry Hines Blvd, Dallas, TX 75390-9040 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1484-1340","authenticated-orcid":false,"given":"Polina A","family":"Egorova","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Neurodegeneration, Peter the Great St. Petersburg Polytechnic University , 29 Polytechnicheskaya str., St. Petersburg 195251 , Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"2024080722300448500_ref1","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s12035-021-02314-z","article-title":"Mutant Ataxin-3-containing aggregates (MATAGGs) in spinocerebellar ataxia type 3: dynamics of the disorder","volume":"58","author":"Raj","year":"2021","journal-title":"Mol Neurobiol"},{"key":"2024080722300448500_ref2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12311-021-01282-3","article-title":"Neurocognitive changes in spinocerebellar ataxia type 3: a systematic review with a narrative design","volume":"21","author":"Yap","year":"2022","journal-title":"Cerebellum"},{"key":"2024080722300448500_ref3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fnins.2020.00749","article-title":"MR imaging of SCA3\/MJD","volume":"14","author":"Wan","year":"2020","journal-title":"Front Neurosci"},{"key":"2024080722300448500_ref4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-510X(02)00110-7","article-title":"Intranuclear inclusions, neuronal loss and CAG mosaicism in two patients with Machado-Joseph disease","volume":"200","author":"Munoz","year":"2002","journal-title":"J Neurol Sci"},{"key":"2024080722300448500_ref5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/brain\/121.4.561","article-title":"The cerebellar cognitive affective syndrome","volume":"121","author":"Schmahmann","year":"1998","journal-title":"Brain J Neurol"},{"key":"2024080722300448500_ref6","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1007\/s00415-021-10516-7","article-title":"The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients","volume":"268","author":"Maas","year":"2021","journal-title":"J Neurol"},{"key":"2024080722300448500_ref7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00415-022-11441-z","article-title":"The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors","volume":"270","author":"Hengel","year":"2023","journal-title":"J Neurol"},{"key":"2024080722300448500_ref8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/hmg\/ddz265","article-title":"Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models","volume":"29","author":"Asher","year":"2020","journal-title":"Hum Mol Genet"},{"key":"2024080722300448500_ref9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12311-023-01520-w","article-title":"Cognitive decline and mood alterations in the mouse model of spinocerebellar ataxia type 2","volume":"23","author":"Marinina","year":"2024","journal-title":"Cerebellum"},{"key":"2024080722300448500_ref10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/hmg\/ddab149","article-title":"Cognitive deficits in episodic ataxia type 2 mouse models","volume":"30","author":"Bohne","year":"2021","journal-title":"Hum Mol Genet"},{"key":"2024080722300448500_ref11","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/hmg\/ddac135","article-title":"Cerebellar contribution to threat probability in a SCA6 mouse model","volume":"31","author":"Bohne","year":"2022","journal-title":"Hum Mol Genet"},{"key":"2024080722300448500_ref12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/hmg\/ddad179","article-title":"Memory decline, anxiety and depression in the mouse model of spinocerebellar ataxia type 3","volume":"33","author":"Marinina","year":"2024","journal-title":"Hum Mol Genet"},{"key":"2024080722300448500_ref13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s12311-021-01349-1","article-title":"Electrophysiological studies support utility of positive modulators of SK channels for the treatment of spinocerebellar ataxia type 2","volume":"21","author":"Egorova","year":"2022","journal-title":"Cerebellum"},{"key":"2024080722300448500_ref14","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1523\/JNEUROSCI.23-07-02600.2003","article-title":"Somatic and dendritic small-conductance calcium-activated potassium channels regulate the output of cerebellar Purkinje neurons","volume":"23","author":"Womack","year":"2003","journal-title":"J Neurosci"},{"key":"2024080722300448500_ref15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/acn3.527","article-title":"Targeting potassium channels to treat cerebellar ataxia","volume":"5","author":"Bushart","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"2024080722300448500_ref16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nn1648","article-title":"Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia","volume":"9","author":"Walter","year":"2006","journal-title":"Nat Neurosci"},{"key":"2024080722300448500_ref17","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.1523\/JNEUROSCI.3582-09.2010","article-title":"The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia","volume":"30","author":"Alvina","year":"2010","journal-title":"J Neurosci"},{"key":"2024080722300448500_ref18","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1523\/JNEUROSCI.6341-09.2010","article-title":"KCa channels as therapeutic targets in episodic ataxia type-2","volume":"30","author":"Alvina","year":"2010","journal-title":"J Neurosci"},{"key":"2024080722300448500_ref19","doi-asserted-by":"crossref","first-page":"15533","DOI":"10.1523\/JNEUROSCI.2454-12.2012","article-title":"Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+\u2212dependent K+-channel activators in Cacna1a(S218L) mutant mice","volume":"32","author":"Gao","year":"2012","journal-title":"J Neurosci"},{"key":"2024080722300448500_ref20","doi-asserted-by":"crossref","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","article-title":"Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3","volume":"31","author":"Shakkottai","year":"2011","journal-title":"J Neurosci"},{"key":"2024080722300448500_ref21","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.chembiol.2012.07.013","article-title":"Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2","volume":"19","author":"Kasumu","year":"2012","journal-title":"Chem Biol"},{"key":"2024080722300448500_ref22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fnins.2020.00279","article-title":"Ataxic symptoms in Huntington's disease transgenic mouse model are alleviated by chlorzoxazone","volume":"14","author":"Egorova","year":"2020","journal-title":"Front Neurosci"},{"key":"2024080722300448500_ref23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","article-title":"Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Romano","year":"2015","journal-title":"Lancet Neurol"},{"key":"2024080722300448500_ref24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.mcn.2018.03.002","article-title":"Calcium-activated SK potassium channels are key modulators of the pacemaker frequency in locus coeruleus neurons","volume":"88","author":"Matschke","year":"2018","journal-title":"Mol Cell Neurosci"},{"key":"2024080722300448500_ref25","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1152\/jn.00913.2015","article-title":"In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model","volume":"115","author":"Egorova","year":"2016","journal-title":"J Neurophysiol"},{"key":"2024080722300448500_ref26","doi-asserted-by":"crossref","first-page":"12588","DOI":"10.1038\/s41598-023-39331-y","article-title":"A chlorzoxazone-folic acid combination improves cognitive affective decline in SCA2-58Q mice","volume":"13","author":"Marinina","year":"2023","journal-title":"Sci Rep"},{"key":"2024080722300448500_ref27","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1523\/JNEUROSCI.1643-12.2012","article-title":"Chronic suppression of inositol 1,4,5-triphosphate receptor-mediated calcium signaling in cerebellar purkinje cells alleviates pathological phenotype in spinocerebellar ataxia 2 mice","volume":"32","author":"Kasumu","year":"2012","journal-title":"J Neurosci"},{"key":"2024080722300448500_ref28","doi-asserted-by":"crossref","first-page":"102319","DOI":"10.1016\/j.ceca.2020.102319","article-title":"In vivo analysis of the spontaneous firing of cerebellar Purkinje cells in awake transgenic mice that model spinocerebellar ataxia type 2","volume":"93","author":"Egorova","year":"2021","journal-title":"Cell Calcium"},{"key":"2024080722300448500_ref29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/hmg\/dds427","article-title":"Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2","volume":"22","author":"Hansen","year":"2013","journal-title":"Hum Mol Genet"},{"key":"2024080722300448500_ref30","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1523\/JNEUROSCI.0891-15.2015","article-title":"Spinocerebellar ataxia type 6 protein aggregates cause deficits in motor learning and cerebellar plasticity","volume":"35","author":"Mark","year":"2015","journal-title":"J Neurosci"},{"key":"2024080722300448500_ref31","doi-asserted-by":"crossref","first-page":"29489","DOI":"10.1038\/srep29489","article-title":"4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6","volume":"6","author":"Jayabal","year":"2016","journal-title":"Sci Rep"},{"key":"2024080722300448500_ref32","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","article-title":"Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3","volume":"28","author":"Chen","year":"2008","journal-title":"J Neurosci"},{"key":"2024080722300448500_ref33","first-page":"165","article-title":"Kinetics of drug action in disease states. XXVII. Effect of experimental renal failure on the pharmacodynamics of zoxazolamine and chlorzoxazone","volume":"246","author":"Yasuhara","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"2024080722300448500_ref34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1023\/A:1015976131643","article-title":"Pharmacodynamics of zoxazolamine and chlorzoxazone in rats","volume":"05","author":"Yasuhara","year":"1988","journal-title":"Pharm Res"},{"key":"2024080722300448500_ref35","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1097\/00001756-200410050-00020","article-title":"Group B vitamins protect murine cerebellar granule cells from glutamate\/NMDA toxicity","volume":"15","author":"Lin","year":"2004","journal-title":"Neuroreport"},{"key":"2024080722300448500_ref36","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12640-019-00119-6","article-title":"Folic acid protects rat cerebellum against oxidative damage caused by homocysteine: the expression of Bcl-2, Bax, and Caspase-3 apoptotic genes","volume":"37","author":"Koohpeyma","year":"2020","journal-title":"Neurotox Res"},{"key":"2024080722300448500_ref37","doi-asserted-by":"crossref","first-page":"106790","DOI":"10.1016\/j.intimp.2020.106790","article-title":"Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo","volume":"88","author":"Bai","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"2024080722300448500_ref38","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148639","article-title":"Prenatal folate deficiency impairs sociability and memory\/recognition in mice offspring","volume":"1822","author":"Yoshikawa","year":"2024","journal-title":"Brain Res"},{"key":"2024080722300448500_ref39","doi-asserted-by":"crossref","first-page":"37486","DOI":"10.1038\/srep37486","article-title":"Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"key":"2024080722300448500_ref40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nut.2018.03.006","article-title":"omega-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress","volume":"53","author":"Reus","year":"2018","journal-title":"Nutrition"},{"key":"2024080722300448500_ref41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1871524921666210114125355","article-title":"Evaluation of the behavioural, Antioxidative and Histomorphological effects of folic acid-supplemented diet in dexamethasone-induced depression in mice","volume":"21","author":"Falade","year":"2021","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"2024080722300448500_ref42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpsychires.2017.07.019","article-title":"The association of folate and depression: a meta-analysis","volume":"95","author":"Bender","year":"2017","journal-title":"J Psychiatr Res"},{"key":"2024080722300448500_ref43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.8157su1c.03","article-title":"Folate in depression: efficacy, safety, differences in formulations, and clinical issues","volume":"70","author":"Fava","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"2024080722300448500_ref44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1021\/acs.jmedchem.1c01473","article-title":"Structure-activity relationship study of subtype-selective positive modulators of KCa2 channels","volume":"65","author":"El-Sayed","year":"2022","journal-title":"J Med Chem"},{"key":"2024080722300448500_ref45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.11.032","article-title":"Involvement of calpain in AMPA-induced toxicity to rat cerebellar Purkinje neurons","volume":"557","author":"Mansouri","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"2024080722300448500_ref46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fnbeh.2014.00133","article-title":"Anxiety- and depression-like behavior in mice lacking the CD157\/BST1 gene, a risk factor for Parkinson's disease","volume":"8","author":"Lopatina","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"2024080722300448500_ref47","article-title":"Novel object recognition test for the investigation of learning and memory in mice","volume":"126","author":"Lueptow","journal-title":"J Vis"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/33\/16\/1406\/58758688\/ddae079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/33\/16\/1406\/58758688\/ddae079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:33:13Z","timestamp":1723077193000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/33\/16\/1406\/7668042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":47,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,5,10]]},"published-print":{"date-parts":[[2024,8,6]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddae079","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8,15]]},"published":{"date-parts":[[2024,5,10]]}}}